AI Article Synopsis
Article Abstract
Proteins are routinely measured in clinical laboratories for diagnosis, prognosis and therapy monitoring. Nevertheless, both test improvements (performance) and innovations (biomarkers) are needed, and protein -glycosylation offers a rich source of potential markers. Here, we have analyzed the total serum -glycome in a matched case-control study (124 cases versus 124 controls) of colorectal cancer patients. The results were validated in an independent sample cohort (both 61 cases versus 61 controls) and further tested in post-operative samples of cured patients. Our results revealed significant differences between patients and controls, with increased size (antennae) and sialylation of the -glycans in the colorectal cancer patient sera as compared to mainly di-antennary -glycans in sera from controls. Furthermore, glycan alterations showed strong associations with cancer stage and survival: The five-year survival rate largely varied between patients with an altered serum N-glycome (46%) and an -glycome similar to controls (87%). Importantly, the total serum -glycome showed prognostic value beyond age and stage. This clinical glycomics study provides novel serum biomarker candidates and shows the potential of total serum -glycans as a prognostic panel. Moreover, serum N-glycome changes reverted to a control-like profile after successful treatment as was demonstrated from pre- and post-operative samples.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078140 | PMC |
| http://dx.doi.org/10.18632/oncotarget.25753 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Glycan profiling of multiple sclerosis oligoclonal bands with MALDI-TOF.
Anal Methods
January 2025
Department of Biochemistry and Molecular Biology, Faculty of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul 34450, Turkey.
Article Synopsis
- Multiple sclerosis (MS) is an autoimmune disease affecting young adults, where the immune system attacks the protective myelin sheath of nerve cells, leading to neurological symptoms.
- The study aims to analyze the glycosylation profiles of immunoglobulin G (IgG) in suspected MS patients through advanced techniques like MALDI-TOF mass spectrometry to identify differences in glycan patterns associated with varying oligoclonal band types.
- Findings indicate that changes in IgG glycosylation may act as potential biomarkers for MS, aiding in understanding the disease's mechanisms and improving diagnostic methods.
Meteorin-like protein alleviates intervertebral disc degeneration by suppressing lipid accumulation in nucleus pulposus cells via PPARα-CPT1A activation.
Biochim Biophys Acta Mol Basis Dis
December 2024
Department of Spine Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. Electronic address:
Article Synopsis
- Lipid metabolism disturbances are linked to intervertebral disc degeneration (IDD), particularly in nucleus pulposus (NP) cells, where there's an imbalance in fat synthesis and usage.
- Exercise may protect against IDD, and myokines like meteorin-like protein (Metrnl) released during exercise could play a role in regulating lipid metabolism in NP cells.
- The study showed that exercise improves IDD by reducing lipid buildup in NP cells, enhancing extracellular matrix health, and further suggests that Metrnl boosts lipid utilization through a mechanism involving carnitine palmitoyltransferase 1A (CPT1A) activation.
A comprehensive view of N-glycosylation as clinical biomarker in prostate cancer.
Biochim Biophys Acta Rev Cancer
December 2024
Dept. Medical Oncology, Ghent University Hospital, Ghent, Belgium; Biomarkers in Cancer research group, Dept. Basic and Applied Medicine, Ghent University, Ghent, Belgium; Cancer Research Institute Ghent, Ghent, Belgium. Electronic address:
Alterations in the prostate cancer (PCa) N-glycome have gained attention as a potential biomarker. This comprehensive review explores the diversity of N-glycosylation patterns observed in PCa-related cell lines, tissue, serum and urine, focusing on prostate-specific antigen (PSA) and the total pool of glycoproteins. Within the context of PCa, altered N-glycosylation patterns are a mechanism of immune escape and a disruption in normal glycoprotein distribution and trafficking.
View Article and Find Full Text PDFStreptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections.
Nat Commun
December 2024
Tropical Diseases Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Article Synopsis
- Knowledge gaps in understanding human immunity to Streptococcus pyogenes have slowed vaccine development, prompting researchers to establish a human challenge model to study this infection.
- The study analyzed antibody responses in serum and saliva from participants, revealing that those who developed pharyngitis had strong serum IgG responses to vaccine antigens but weaker mucosal IgA responses.
- The findings indicate that past exposure to the bacteria affects immune responses, underscoring the need to consider these complexities when evaluating potential vaccines in future trials.
Identification of serum N-glycans signatures in three major gastrointestinal cancers by high-throughput N-glycome profiling.
Clin Proteomics
November 2024
The Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics-Hubei Bioinformatics & Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, No. 1037 Luoyudong Road, Hongshan District, Wuhan, 430074, China.
Background: Alternative N-glycosylation of serum proteins has been observed in colorectal cancer (CRC), esophageal squamous cell carcinoma (ESCC) and gastric cancer (GC), while comparative study among those three cancers has not been reported before. We aimed to identify serum N-glycans signatures and introduce a discriminative model across the gastrointestinal cancers.
Methods: The study population was initially screened according to the exclusion criteria process.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!